Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
Healthcare Professionals / OncoLink Scientific Meetings Coverage / PTCOG / OncoLink at PTCOG 2009 / October 3, 2009
OncoLink reporters provide up-to-date coverage of the Particle Therapy Cooperative Group (PTCOG) 48 Conference in Heidelberg, Germany, September 28 - October 3, 2009.
|
Carbon Ion Radiotherapy for Head and Neck Tumors Invading the Skull Base
Presenter: A. Hasegawa, J. E. Mizoe, K. Jingu, H. Bessho, T. Kamada, H. TsujiiPresenter's Affiliation: Research Center for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, JapanType of Session: ScientificBackground ... |
|
|
Carbon Ion Therapy for Patients with Pancreas Cancer
Presenter: Dr. S. YamadaPresenter's Affiliation: Chiba University, Chiba JapanType of Session: ScientificBackground The treatment of pancreatic cancer remains a therapeutic challenge. The majority of patients are unresectable at the time of... |
|
|
Hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme
Presenter: Dr. K. TsuboiPresenter's Affiliation: Proton Medical Research Center, University of Tsukuba, Tsukuba, JapanType of Session: ScientificBackground Despite aggressive multimodality treatment, outcomes in glioblastoma (GBM) remains poor,... |
|
|
Particle Therapy for Bone and Soft Tissue Sarcomas: A Retrospective Study
Presenter: Y. Demizu , M. Murakami, D. Miyawaki, M. Mima, K. Terashima, T. Arimura, Y. Niwa, Y. Hishikawa Presenter's Affiliation: Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, JapanType of Session: ScientificBackground Bone... |
|
|
Proton radiation therapy of ocular melanoma at PSI - long-term clinical exam
Presenter: G. Goitein, A. Schalenbourg, J. Verwey, A. Bolsi, C. Ares, L. Chamot, E. Hug, L. ZografosPresenter's Affiliation: Paul Scherrer Institute (PSI) Villigen, Switzerland Type of Session: ScientificBackground There are approximately 2200... |
|
|
Proton Radiotherapy for Pediatric Ewing's Sarcomas: Initial Clinical Outcomes of 29 Patients
Presenter: B. RombiPresenter's Affiliation: Trento, ItalyType of Session: ScientificBackground Ewing’s sarcoma represents the second most common bone tumor in children; the Ewing’s family of tumors includes osseous Ewing’s... |
|
|
Proton Therapy of Nasal Cavity and Paranasal Sinus Tumors: The UFPTI Experience
Presenter: Dr. R. MalyapaPresenter's Affiliation: University of Florida Proton Therapy Institute, Jacksonville, Florida, USAType of Session: ScientificBackground Compared with 3D conformal radiation therapy, a number of studies have suggested... |
|
|
Proton therapy of ocular tumors for very young children under general anesthesia
Presenter: J. HeufelderPresenter's Affiliation: Berlin, GermanyType of Session: ScientificBackground Ocular tumors represent an important subset of pediatric malignancies, often affecting very young children. Most children with... |
Dr. Hill-Kayser talks about working in oncology care and how her line of work can be particularly rewarding. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

